Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Robert L. Herting"'
Publikováno v:
Neurology. 46:420-424
We tested the ability of d-cycloserine, a partial glycine agonist acting at the N-methyl-D-aspartate (NMDA) receptor complex, to improve implicit memory in Alzheimer patients in a parallel-group, placebo-controlled, double-blind study. One-hundred ei
Autor:
Fumisuke Matsuo, Hugh C. Hendrie, Robert L. Herting, John J. Sramek, Neal R. Cutler, Ward T. Smith, T. Daniel Fakouhi
Publikováno v:
Journal of Geriatric Psychiatry and Neurology. 6:115-119
A multicenter, double-blind, placebo-controlled, parallel group study was conducted to assess the safety and efficacy of three doses of milacemide in the treatment of patients with senile dementia of the Alzheimer type of mild to moderate severity. P
Autor:
Robert L. Herting, Janet A. Camp-Bruno
Publikováno v:
Psychopharmacology. 115(1-2)
Cognitive effects of the novel glycine prodrug milacemide (400 mg), the catecholaminergic agonist methylphenidate (20 mg), and placebo were evaluated in 48 healthy young adults. Throughout a 6-h drug treatment day, subjects repeatedly performed tests
Publikováno v:
European journal of pharmacology. 257(1-2)
The memory-enhancing potential of D-cycloserine (cycloserine) a partial agonist at the glycine recognition site on the NMDA receptor, was evaluated in mice using a thirst-motivated linear maze learning task. Immediate acute post-training injections (
Publikováno v:
Clinical neuropharmacology. 15(2)
Prior research has shown that memory for facts and items (item memory) and memory for where one has learned these items (source memory) can be dissociated under certain conditions. In this study, we examined the effects of milacemide, a derivative of
Publikováno v:
Neurology. 41(9)
Modulation of glycine concentrations in the brain influences learning and memory functions in experimental animals. We administered Milacemide, a glycine prodrug, or placebo to young and older healthy adults, who performed a word-retrieval task. Mila
Publikováno v:
Pharmacology, biochemistry, and behavior. 39(1)
The objective of this study was to evaluate the effectiveness of milacemide as a memory-enhancing drug in mice. Experiment 1 showed that forgetting of active avoidance learning produced by a 14-day training to test delay could be alleviated by milace
Autor:
Robert L. Herting
Publikováno v:
Annals of the New York Academy of Sciences. 640
Interest in the NMDA receptor as a key mechanism in long-term potentiation and possibly improved learning and memory has led to the development of milacemide as a prodrug for glycine, a modulator of the NMDA receptor. Trials of milacemide in doses ra
Publikováno v:
Biological Psychiatry. 37:596
Autor:
N. Dorin Ischlondsky, Robert Efron, Irving Mauer, André M. Bennett, Edwin O. Willis, Frederick L. Moolten, Roger G. Hart, Edwin T. Harper, Dwight J. Ingle, Robert L. Herting, Jack Benjamin
Publikováno v:
Perspectives in Biology and Medicine. 12:163-176